Combination of LTC004 and Regorafenib to Treat Patients With Advanced/Metastatic CRC
Clinical trial NCT06322563 · UNKNOWN
Trial details
- NCT number
- NCT06322563
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2025-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.